ASCO GI: GLP-1 Receptor Agonist Use Linked to Reduced CRC Incidence

MONDAY, Jan. 12, 2026-- Glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with a reduced risk for colorectal cancer (CRC) incidence compared with aspirin, according to a study presented at the American Society of Clinical...